<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7742037" created="15/06/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7742037</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="HIV_type_1_protease_activation" sem="Other"><term id="T2" lex="HIV_type_1" sem="Virus">HIV type 1</term> <term id="T3" lex="protease" sem="Protein_family_or_group">protease</term> activation</term> of <term id="T4" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> within <term id="T5" lex="T_lymphoid_cell" sem="Cell_natural">T lymphoid cells</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Positive_regulation"/>
<theme idref="T4"/>
<cause idref="T2"/>
<clue>HIV type 1 protease <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B <clueLoc>within T lymphoid cells.</clueLoc></clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T6" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> is a <term id="T7" lex="nuclear_protein" sem="Protein_family_or_group">nuclear protein</term> of the <term id="T8" lex="rel_oncogene_family" sem="Protein_family_or_group">rel oncogene family</term> capable of enhancing transcription of <term id="T9" lex="several_cellular_gene" sem="DNA_family_or_group">several cellular genes</term>, including <term id="T10" lex="IL-2" sem="Protein_molecule">IL-2</term> and the <term id="T11" lex="IL-2_receptor" sem="Protein_molecule"><term id="T12" lex="IL-2" sem="Protein_molecule">IL-2</term> receptor</term>, and <term id="T13" lex="viral_gene" sem="DNA_family_or_group">viral genes</term> transcribed from the <term id="T14" lex="HIV-1_LTR" sem="DNA_domain_or_region">HIV-1 LTR</term>.</sentence>
<event KT="Other" id="E2">
<type class="Transcription"/>
<theme idref="T10"/>
<clue>NF-kappa B is a nuclear protein of the rel oncogene family capable of enhancing <clueType>transcription</clueType> <linkTheme>of</linkTheme> <corefTheme>several cellular genes</corefTheme>, including IL-2 and the IL-2 receptor, and viral genes transcribed from the HIV-1 LTR.</clue>
</event>
<event KT="Other" id="E3">
<type class="Transcription"/>
<theme idref="T11"/>
<clue>NF-kappa B is a nuclear protein of the rel oncogene family capable of enhancing <clueType>transcription</clueType> <linkTheme>of</linkTheme> <corefTheme>several cellular genes</corefTheme>, including IL-2 and the IL-2 receptor, and viral genes transcribed from the HIV-1 LTR.</clue>
</event>
<event KT="Other" id="E4">
<type class="Transcription"/>
<theme idref="T13"/>
<clue>NF-kappa B is a nuclear protein of the rel oncogene family capable of enhancing <clueType>transcription</clueType> <linkTheme>of</linkTheme> <corefTheme>several cellular genes</corefTheme>, including IL-2 and the IL-2 receptor, and viral genes transcribed from the HIV-1 LTR.</clue>
</event>
<event CL="L2" KT="Analysis" id="E5">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T8"/>
<clue>NF-kappa B is a nuclear protein of the rel oncogene family <clueKT><clueCL>capable of</clueCL></clueKT> <clueType>enhancing</clueType> transcription of several cellular genes, including IL-2 and the IL-2 receptor, and viral genes transcribed from the HIV-1 LTR.</clue>
</event>
<event CL="L2" KT="Analysis" id="E6">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T8"/>
<clue>NF-kappa B is a nuclear protein of the rel oncogene family <clueKT><clueCL>capable of</clueCL></clueKT> <clueType>enhancing</clueType> transcription of several cellular genes, including IL-2 and the IL-2 receptor, and viral genes transcribed from the HIV-1 LTR.</clue>
</event>
<event CL="L2" KT="Analysis" id="E7">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T8"/>
<clue>NF-kappa B is a nuclear protein of the rel oncogene family <clueKT><clueCL>capable of</clueCL></clueKT> <clueType>enhancing</clueType> transcription of several cellular genes, including IL-2 and the IL-2 receptor, and viral genes transcribed from the HIV-1 LTR.</clue>
</event>
<event KT="Other" id="E50">
<type class="Transcription"/>
<theme idref="T13"/>
<clue>NF-kappa B is a nuclear protein of the rel oncogene family capable of enhancing transcription of several cellular genes, including IL-2 and the IL-2 receptor, and viral genes <clueType>transcribed</clueType> from the HIV-1 LTR.</clue>
</event>
<event KT="Other" id="E51">
<type class="Positive_regulation"/>
<theme idref="E50"/>
<cause idref="T14"/>
<clue>NF-kappa B is a nuclear protein of the rel oncogene family capable of enhancing transcription of several cellular genes, including IL-2 and the IL-2 receptor, and viral genes transcribed <linkCause>from</linkCause> the HIV-1 LTR.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S3">It has been reported that <term id="T15" lex="HIV-1_protease" sem="Protein_molecule">HIV-1 protease</term> may cleave the <term id="A2" sem="Protein_molecule"><term id="T16" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> precursor</term> to its active form in vitro.</sentence>
<event KT="Other" id="E108" uncertainty="probable">
<type class="Protein_processing"/>
<theme idref="A2"/>
<clue>It has been reported that HIV-1 protease may <clueType>cleave</clueType> the NF-kappa B precursor to its active form in vitro.</clue>
<comment>CAUTION, &quot;its active form&quot; vague to be PRODUCT</comment></event>
<event CL="L1" KT="Analysis" Source="Other" id="E8">
<type class="Positive_regulation"/>
<theme idref="E108"/>
<cause idref="T15"/>
<clue>It <clueSource>has been</clueSource> <clueKT>reported</clueKT> that HIV-1 protease <clueCL>may</clueCL> cleave the NF-kappa B precursor to its active form in vitro.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S4">In this study the effects of <term id="A3" sem="Protein_molecule"><term id="T17" lex="HIV" sem="Virus">HIV</term> protease</term> on <term id="T18" lex="NF-kappa_B_precursor_activation" sem="Other"><term id="A21" sem="Protein_molecule"><term id="T19" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> precursor</term> activation</term> were examined in Jurkat <term id="T20" lex="T_cell" sem="Cell_natural">T cells</term> by introducing a <term id="T21" lex="protease_expression_vector" sem="DNA_molecule">protease expression vector</term> into the cells.</sentence>
<event KT="Other" id="E9">
<type class="Positive_regulation"/>
<theme idref="A21"/>
<clue>In this study the effects of HIV protease on NF-kappa B precursor <clueType>activation</clueType> were examined in Jurkat T cells by introducing a protease expression vector into the cells.</clue>
</event>
<event KT="Investigation" id="E10" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E9"/>
<cause idref="A3"/>
<clue>In this study the <clueType>effects</clueType> <linkCause>of</linkCause> HIV protease <linkTheme>on</linkTheme> NF-kappa B precursor activation were <clueKT>examined</clueKT> <clueLoc>in Jurkat T cells</clueLoc> <clueExperiment>by introducing a protease expression vector into the cells</clueExperiment>.</clue>
</event>
<event KT="Other" id="E100">
<type class="Gene_expression"/>
<theme idref="A3"/>
<clue>In this study the effects of HIV protease on NF-kappa B precursor activation were examined in Jurkat T cells by introducing a <corefTheme>protease</corefTheme> <clueType>expression</clueType> vector into the cells.</clue>
</event>
<event KT="Other" id="E101">
<type class="Positive_regulation"/>
<theme idref="E100"/>
<clue>In this study the effects of HIV protease on NF-kappa B precursor activation were examined <clueLoc>in Jurkat T cells</clueLoc> by <clueType>introducing</clueType> a protease expression vector into the cells.</clue>
</event>
<sentence id="S5">Increased <term id="T22" lex="NF-kappa_B_activity" sem="Other"><term id="T23" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activity</term> was observed and this increased activity was blocked by a specific <term id="A4" sem="Other">inhibitor of the <term id="T24" lex="viral_protease" sem="Protein_molecule">viral protease</term></term>.</sentence>
<event id="E12">
<type class="Positive_regulation"/>
<theme idref="T22"/>
<cause idref="E101"/>
<clue><clueType>Increased</clueType> NF-kappa B activity was <clueKT>observed</clueKT> and this increased activity was blocked by a specific inhibitor of the viral protease.</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E13">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="A4"/>
<clue>Increased NF-kappa B activity was observed and <corefTheme>this increased activity</corefTheme> was <clueType>blocked</clueType> <linkCause>by</linkCause> a specific inhibitor of the viral protease.</clue>
<comment>TPS: A4</comment></event>
<sentence id="S6"><term id="A5" sem="Other">Viral transcription</term>, as measured using <term id="T25" lex="LTR-CAT_assay" sem="Other"><term id="T26" lex="LTR" sem="DNA_domain_or_region">LTR</term><term id="T27" lex="CAT" sem="Protein_molecule">-CAT</term> assays</term>, was only slightly enhanced in the <term id="T28" lex="HIV-protease_expressing_cell" sem="Cell_natural"><term id="A30" sem="Protein_family_or_group">HIV-protease</term> expressing cells</term>, while secretion of <term id="T29" lex="IL-2" sem="Protein_molecule">IL-2</term> and expression of the <term id="A6" sem="Protein_molecule"><term id="T30" lex="IL-2" sem="Protein_molecule">IL-2</term> receptor</term> were not affected.</sentence>
<event KT="Analysis" id="E15">
<type class="Positive_regulation"/>
<theme idref="A5"/>
<clue>Viral transcription, <clueExperiment>as <clueKT>measured</clueKT> using LTR-CAT assays,</clueExperiment> was only slightly <clueType>enhanced</clueType> <clueLoc>in the HIV-protease expressing cells</clueLoc>, while secretion of IL-2 and expression of the IL-2 receptor were not affected.</clue>
</event>
<event id="E16">
<type class="Localization"/>
<theme idref="T29"/>
<clue>Viral transcription, as measured using LTR-CAT assays, was only slightly enhanced in the HIV-protease expressing cells, while <clueType>secretion</clueType> <linkTheme>of</linkTheme> IL-2 and expression of the IL-2 receptor were not affected.</clue>
</event>
<event id="E17">
<type class="Gene_expression"/>
<theme idref="A6"/>
<clue>Viral transcription, as measured using LTR-CAT assays, was only slightly enhanced in the HIV-protease expressing cells, while secretion of IL-2 and <clueType>expression</clueType> <linkTheme>of</linkTheme> the IL-2 receptor were not affected.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E18">
<type class="Regulation"/>
<theme idref="E16"/>
<clue>Viral transcription, as measured using LTR-CAT assays, was only slightly enhanced <clueLoc>in the HIV-protease expressing cells</clueLoc>, while secretion of IL-2 and expression of the IL-2 receptor were <cluePolarity>not</cluePolarity> <clueType>affected</clueType>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E19">
<type class="Regulation"/>
<theme idref="E17"/>
<clue>Viral transcription, as measured using LTR-CAT assays, was only slightly enhanced <clueLoc>in the HIV-protease expressing cells</clueLoc>, while secretion of IL-2 and expression of the IL-2 receptor were <cluePolarity>not</cluePolarity> <clueType>affected</clueType>.</clue>
</event>
<event KT="Other" id="E60">
<type class="Gene_expression"/>
<theme idref="A30"/>
<clue>Viral transcription, as measured using LTR-CAT assays, was only slightly enhanced in the HIV-protease <clueType>expressing</clueType> <clueLoc>cells</clueLoc>, while secretion of IL-2 and expression of the IL-2 receptor were not affected.</clue>
</event>
<sentence id="S7">The limited activation of <term id="T31" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> by <term id="T32" lex="HIV_protease" sem="Protein_molecule">HIV protease</term> appears unlikely to have a significant effect on <term id="T33" lex="virus_expression" sem="Other"><term id="A7" sem="Virus">virus</term> expression</term> or <term id="T34" lex="T_cell_function" sem="Other">T cell function</term>.</sentence>
<event KT="Other" Manner="Low" id="E20">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<cause idref="T32"/>
<clue>The <clueManner>limited</clueManner> <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B <linkCause>by</linkCause> HIV protease appears unlikely to have a significant effect on virus expression or T cell function.</clue>
</event>
<event KT="Other" id="E21">
<type class="Viral_life_cycle"/>
<theme idref="A7"/>
<clue>The limited activation of NF-kappa B by HIV protease appears unlikely to have a significant effect on virus <clueType>expression</clueType> or T cell function.</clue>
</event>
<event CL="L2" KT="Analysis" Manner="High" Polarity="Negative" assertion="non-exist" id="E23">
<type class="Regulation"/>
<theme idref="T34"/>
<cause idref="E20"/>
<clue>The limited activation of NF-kappa B by HIV protease <clueKT><clueCL>appears</clueCL></clueKT> <cluePolarity>unlikely</cluePolarity> to have a <clueManner>significant</clueManner> <clueType>effect</clueType> <linkTheme>on</linkTheme> virus expression or T cell function.</clue>
</event>
<event CL="L2" KT="Analysis" Manner="High" Polarity="Negative" assertion="non-exist" id="E24">
<type class="Regulation"/>
<theme idref="E21"/>
<cause idref="E20"/>
<clue>The limited activation of NF-kappa B by HIV protease <clueKT><clueCL>appears</clueCL></clueKT> <cluePolarity>unlikely</cluePolarity> to have a <clueManner>significant</clueManner> <clueType>effect</clueType> <linkTheme>on</linkTheme> virus expression or T cell function.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
